ANIDO ARMANDO

CIK 00012198667 companiesEXTON, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001219866

Recent Transactions

50 trades

Award
SCYNEXIS INC$SCYX
Stock Option
2025-06-26+23,000→ 23,000 total
Award
SCYNEXIS INC$SCYX
Common Stock
2025-06-26+23,000→ 71,000 total
Award
SCYNEXIS INC$SCYX
Stock Option
2024-06-20+23,000→ 23,000 total
Award
SCYNEXIS INC$SCYX
Common Stock
2024-06-20+23,000→ 48,000 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-10-10+240,000→ 610,000 total
Disposition from Tender
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-10-10−26,595→ 0 total
Disposition from Tender
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-10-10−610,000→ 0 total
Disposition from Tender
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-10-10−566,722→ 370,000 total
Disposition from Tender
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-10-10−13,297→ 0 total
Disposition to Issuer
Zynerba Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2023-10-10−190,000→ 0 total
Sale
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-09-13$1.33/sh−17,830→ 936,722 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-09-12+64,747→ 954,552 total
Award
SCYNEXIS INC$SCYX
Common Stock
2023-06-15+10,000→ 25,000 total
Award
SCYNEXIS INC$SCYX
Stock Option
2023-06-15+10,000→ 10,000 total
Tax Payment
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-02-08$0.60/sh−12,547→ 889,805 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-02-07+45,406→ 902,352 total
Tax Payment
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-02-01$0.60/sh−11,726→ 856,946 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-01-31+42,437→ 868,672 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-01-24+250,000→ 826,235 total
Sale
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-01-23$0.60/sh−35,453→ 576,235 total
Sale
Zynerba Pharmaceuticals, Inc.
Common Stock
2022-07-19$1.10/sh−11,899→ 611,688 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2022-07-18+43,164→ 623,587 total
Award
SCYNEXIS INC$SCYX
Common Stock
2022-06-17+10,000→ 15,000 total
Award
SCYNEXIS INC$SCYX
Stock Option (Right to Buy)
2022-06-17+10,000→ 10,000 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-01-26+190,000→ 190,000 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2022-01-26+120,000→ 580,423 total
Award
SCYNEXIS INC$SCYX
Stock Option (Right to Buy)
2021-06-16+10,000→ 10,000 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2021-01-21+161,867→ 161,867 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2021-01-21+107,911→ 460,423 total
Award
SCYNEXIS INC$SCYX
Common Stock Warrant
2020-12-21+2,500→ 2,500 total
Award
SCYNEXIS INC$SCYX
Common Stock Warrant
2020-12-21+2,500→ 2,500 total
Purchase
SCYNEXIS INC$SCYX
Common Stock
2020-12-21$6.25/sh+5,000→ 5,000 total
Award
SCYNEXIS INC$SCYX
Stock Option (Right to Buy)
2020-07-06+55,000→ 55,000 total
Award
SCYNEXIS INC$SCYX
Stock Option (Right to Buy)
2020-07-06+45,000→ 45,000 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2020-01-30+162,480→ 162,480 total
Award
SCYNEXIS INC$SCYX
Stock Option (Right to Buy)
2019-06-18+45,000→ 45,000 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2019-01-24+160,000→ 160,000 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2019-01-24+160,000→ 160,000 total
Award
SCYNEXIS INC$SCYX
Stock Option (right to buy)
2019-01-21+70,000→ 70,000 total
Purchase
Zynerba Pharmaceuticals, Inc.
Common Stock
2018-08-06$5.96/sh+15,000→ 352,512 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2018-01-11+81,000→ 81,000 total
Award
Vaxart, Inc.$VXRT
Stock Option (Right to Buy)
2017-05-18$0.49/sh+20,000→ 75,000 total
Purchase
Zynerba Pharmaceuticals, Inc.
Common Stock
2017-05-15$19.57/sh+1,500→ 337,512 total
Purchase
Zynerba Pharmaceuticals, Inc.
Common Stock
2017-05-12$19.76/sh+3,500→ 336,012 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2017-01-25+125,000→ 125,000 total
Award
Vaxart, Inc.$VXRT
Stock Option (Right to Buy)
2016-05-12$1.50/sh+20,000→ 20,000 total
Award
Vaxart, Inc.$VXRT
Stock Option (Right to Buy)
2015-09-21$1.95/sh+35,000→ 35,000 total
Conversion
Zynerba Pharmaceuticals, Inc.
Common Stock
2015-08-10+26,595→ 26,595 total
Conversion
Zynerba Pharmaceuticals, Inc.
Series 1 Convertible Preferred Stock
2015-08-10−50,000→ 0 total
Conversion
Zynerba Pharmaceuticals, Inc.
Common Stock
2015-08-10+13,297→ 13,297 total

Companies

Recent Filings

Address

700 PENNSYLVANIA DR.

EXTON, PA, 19341

View on SEC.gov